| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Homo sapiens
|
Irfan Asangani
|
||||||
| GSE197557 |
AKT/ERK-mediated activation of CDK7-MED1-AR axis drives resistance to pan BET bromodomain inhibitor ZEN-3694 in advanced prostate cancer [RNA-Seq]
|
|
12 | Irfan Asangani | Mar 05, 2022 | |||
| GSE197772 |
AKT/ERK-mediated activation of CDK7-MED1-AR axis drives resistance to pan BET bromodomain inhibitor ZEN-3694 in advanced prostate cancer [Exome-Seq]
|
|
4 | Irfan Asangani | Mar 05, 2022 | |||
| GSE197773 |
AKT/ERK-mediated activation of CDK7-MED1-AR axis drives resistance to pan BET bromodomain inhibitor ZEN-3694 in advanced prostate cancer
|
|
16 | Irfan Asangani | Mar 05, 2022 | |||
| GSE205348 |
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance
|
|
11 | Irfan Asangani | Jun 08, 2023 | |||
| GSE205419 |
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance
|
|
28 | Irfan Asangani | Jun 07, 2023 |
